Geriatric Nutritional Risk Index predicts bleeding event in patients with heart failure

Abstract Aims We aimed to elucidate the association between malnutrition and the occurrence of bleeding events in patients with heart failure. Methods and results We evaluated the nutritional status of patients with heart failure [n = 2044, median (inter‐quartile range) age 69.0 (59.0–78.0) years, 1209 (59.1%) males] using the Geriatric Nutritional Risk Index (GNRI). The primary endpoint was a composite of bleeding events such as haemorrhagic stroke or gastrointestinal bleeding. According to the survival classification and regression tree analysis, the accurate cut‐off point of GNRI for predicting the primary endpoint was 106.2. We divided the patients into two groups based on GNRI levels: high GNRI group (GNRI ≥ 106.2, n = 606, 29.6%) and low GNRI group (GNRI < 106.2, n = 1438, 70.4%). We compared the patients' characteristics and prognosis between the two groups. The low GNRI group was older [72.0 (63.0–79.0) vs. 63.0 (53.0–73.0) years, P < 0.001] and had a lower prevalence of male sex (56.9% vs. 64.5%, P = 0.001). There were no differences in the use of antiplatelet agents and anticoagulants between the two groups. Levels of B‐type natriuretic peptide were higher [321.1 (123.3–667.4) vs. 111.6 (42.6–235.4) pg/mL, P < 0.001] and levels of haemoglobin were lower [12.4 (10.8–13.7) vs. 14.2 (12.9–15.4) g/dL, P < 0.001] in the low GNRI group. The Kaplan–Meier analysis demonstrated that bleeding event rates were higher in the low GNRI group (log‐rank P < 0.001). The multivariable Cox proportional hazard analysis revealed that low GNRI (hazard ratio 1.952, 95% confidence interval 1.002–3.805, P = 0.049) was associated with bleeding events. Conclusions Heart failure patients with poor nutritional status, determined by GNRI under 106.2, experienced high bleeding event rates. Comprehensive management is required to avoid bleeding event in those populations.

[1]  A. Vlasova,et al.  Mechanisms of Kwashiorkor-Associated Immune Suppression: Insights From Human, Mouse, and Pig Studies , 2022, Frontiers in Immunology.

[2]  Y. Takeishi,et al.  B-type natriuretic peptide is associated with the occurrence of bleeding events in heart failure patients with a history of coronary artery disease. , 2022, Journal of cardiology.

[3]  J. McMurray,et al.  2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure , 2022, European journal of heart failure.

[4]  J. McMurray,et al.  2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. , 2021, European heart journal.

[5]  Masaki Kodaira,et al.  Female sex as an independent predictor of high bleeding risk among East Asian percutaneous coronary intervention patients: A sex difference analysis. , 2021, Journal of cardiology.

[6]  Shigeru Tanaka,et al.  Association between geriatric nutritional risk index and stroke risk in hemodialysis patients: 10-Years outcome of the Q-Cohort study. , 2021, Atherosclerosis.

[7]  Samiran Ghosh,et al.  Survival trees based on heterogeneity in time‐to‐event and censoring distributions using parameter instability test , 2020, Stat. Anal. Data Min..

[8]  Y. Takeishi,et al.  Incidence and subsequent prognostic impacts of gastrointestinal bleeding in patients with heart failure , 2020, European journal of preventive cardiology.

[9]  I. Benedek,et al.  Altered nutritional status, inflammation and systemic vulnerability in patients with acute myocardial infarction undergoing percutaneous coronary revascularisation: A prospective study in a level 3 cardiac critical care unit. , 2020, Nutrition & dietetics: the journal of the Dietitians Association of Australia.

[10]  T. Kitazono,et al.  Prasugrel for Japanese Patients With Ischemic Heart Disease in Long-Term Clinical Practice (PRASFIT-Practice II) - 1-Year Follow-up Results of a Postmarketing Observational Study. , 2019, Circulation journal : official journal of the Japanese Circulation Society.

[11]  T. Murohara,et al.  Impact of Nutritional and Inflammation Status on Long-Term Bleeding in Patients Undergoing Percutaneous Coronary Intervention with an Oral Anticoagulant , 2019, Journal of atherosclerosis and thrombosis.

[12]  D. Gallo,et al.  Anemia in patients with acute coronary syndromes treated with prasugrel or ticagrelor: Insights from the RENAMI registry. , 2018, Thrombosis research.

[13]  Shigeru Tanaka,et al.  Association of geriatric nutritional risk index with infection-related mortality in patients undergoing hemodialysis: The Q-Cohort Study. , 2018, Clinical nutrition.

[14]  Y. Takeishi,et al.  Impact of nutritional indices on mortality in patients with heart failure , 2018, Open Heart.

[15]  H. Völzke,et al.  Geriatric nutritional risk index correlates with length of hospital stay and inflammatory markers in older inpatients. , 2017, Clinical nutrition.

[16]  H. Daida,et al.  Prognostic Impact of the Geriatric Nutritional Risk Index on Long-Term Outcomes in Patients Who Underwent Percutaneous Coronary Intervention. , 2017, The American journal of cardiology.

[17]  Y. Takeishi,et al.  Associations of Acid Suppressive Therapy With Cardiac Mortality in Heart Failure Patients , 2017, Journal of the American Heart Association.

[18]  Deepak L. Bhatt,et al.  Derivation and validation of the predicting bleeding complications in patients undergoing stent implantation and subsequent dual antiplatelet therapy (PRECISE-DAPT) score: a pooled analysis of individual-patient datasets from clinical trials , 2017, The Lancet.

[19]  S. Anker,et al.  Intestinal congestion and right ventricular dysfunction: a link with appetite loss, inflammation, and cachexia in chronic heart failure. , 2016, European heart journal.

[20]  S. Pocock,et al.  Coronary Thrombosis and Major Bleeding After PCI With Drug-Eluting Stents: Risk Scores From PARIS. , 2016, Journal of the American College of Cardiology.

[21]  K. Jeejeebhoy,et al.  Malnutrition and Cachexia in Heart Failure. , 2016, JPEN. Journal of parenteral and enteral nutrition.

[22]  J. Spertus,et al.  Development and Validation of a Prediction Rule for Benefit and Harm of Dual Antiplatelet Therapy Beyond 1 Year After Percutaneous Coronary Intervention. , 2016, JAMA.

[23]  M. Sawyer,et al.  Sarcopenic obesity and myosteatosis are associated with higher mortality in patients with cirrhosis , 2015, Journal of cachexia, sarcopenia and muscle.

[24]  A. Gossum,et al.  Diagnostic criteria for malnutrition - An ESPEN Consensus Statement. , 2015, Clinical nutrition.

[25]  S. Anker,et al.  Intestinal blood flow in patients with chronic heart failure: a link with bacterial growth, gastrointestinal symptoms, and cachexia. , 2014, Journal of the American College of Cardiology.

[26]  Hiroshi Takahashi,et al.  Geriatric nutritional risk index accurately predicts cardiovascular mortality in incident hemodialysis patients. , 2014, Journal of cardiology.

[27]  G. Rogler,et al.  The heart and the gut. , 2014, European heart journal.

[28]  E. Antman,et al.  Edoxaban versus warfarin in patients with atrial fibrillation. , 2013, The New England journal of medicine.

[29]  Y. Kanda,et al.  Investigation of the freely available easy-to-use software ‘EZR' for medical statistics , 2012, Bone Marrow Transplantation.

[30]  G. Stone,et al.  Long-term impact of chronic kidney disease in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention: the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) trial. , 2011, JACC. Cardiovascular interventions.

[31]  P. Clark,et al.  Nutrient Intake in Heart Failure Patients , 2008, The Journal of cardiovascular nursing.

[32]  Y. Kihara,et al.  B-type natriuretic peptide strongly reflects diastolic wall stress in patients with chronic heart failure: comparison between systolic and diastolic heart failure. , 2006, Journal of the American College of Cardiology.

[33]  Luigi Tavazzi,et al.  Acute Heart Failure Syndromes: Current State and Framework for Future Research , 2005, Circulation.

[34]  Ioannis Nicolis,et al.  Geriatric Nutritional Risk Index: a new index for evaluating at-risk elderly medical patients. , 2005, The American journal of clinical nutrition.

[35]  K. Kalantar-Zadeh,et al.  Relative contributions of nutrition and inflammation to clinical outcome in dialysis patients. , 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[36]  S. Pikkarainen,et al.  Mechanical load-induced alterations in B-type natriuretic peptide gene expression. , 2001, Canadian journal of physiology and pharmacology.

[37]  Rickham Pp Human Experimentation: Code of Ethics of W.M.A , 1964 .

[38]  D. Xavier,et al.  Apixaban versus Warfarin in Patients with Atrial Fibrillation , 2012 .

[39]  S. Anker,et al.  The gut and intestinal bacteria in chronic heart failure. , 2009, Current drug metabolism.

[40]  P. P. Rickham HUMAN EXPERIMENTATION. CODE OF ETHICS OF THE WORLD MEDICAL ASSOCIATION. DECLARATION OF HELSINKI. , 1964, British medical journal.